PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320182
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320182
DNA Synthesizers Market size was valued at USD 2,807.9 Million in 2022, expanding at a CAGR of 20.2% from 2023 to 2030.
DNA synthesizers are machines used to custom-build DNA molecules to contain a specific sequence of nucleotides. They can create specific DNA molecules for use in the treatment of a variety of diseases by replacing a faulty or damaged section of DNA with a repaired section. Using DNA synthesizers, researchers can create specific DNA sequences that adapt to their own requirements. Applications such as molecular cloning, gene synthesis, genetic engineering, and gene editing all require this ability. DNA synthesizers can generate particular DNA molecules for use in the treatment of a number of diseases. Researchers are considering gene therapy as a potential treatment for neurological conditions like Parkinson's and Alzheimer's. By delivering specific genes to the brain, gene therapy aims to improve neuronal survival and prevent further degeneration.
There has been an increase in the use of DNA synthesis in a variety of sectors, including medical, diagnostic, academic, and industrial research. DNA synthesis is essential to genetic research because it enables the creation of unique DNA sequences for the investigation of protein structure, gene function, and gene expression. Generating genomic data requires significant financial support from institutions such as the National Human Genome Research Institute (NHGRI), which provides over USD 125 million each year to support various genomic data science endeavors. The market for DNA synthesizers has expanded as more academic institutions and industrial research labs use these tools to support their initiatives. Recent advances in genetic engineering have created new opportunities for the suitable engineering of biological systems. However, the interaction of the individual's environment and behavior with their genes, known as epigenetic effects, alters how their genes function. Such DNA sequencing-related risks serve as a barrier to the market, preventing market growth.
The Global DNA Synthesizers Market is segmented on the basis of Product Type, Application, End-User, and Region.
The market is divided into three categories based on product type: Benchtop DNA Synthesizers and Automated DNA Synthesizers. Automated DNA Synthesizers are expected to dominate the market growth. Automated DNA Synthesizers are an advancement of traditional DNA synthesizers, with improved automation and robotic capabilities that help accelerate the DNA synthesis process.
The market is divided into two categories based on application: Research and Development, Diagnostics, and Therapeutics. Diagnostics is expected to dominate the market growth. DNA synthesizers are used in molecular diagnostics to create custom DNA probes, primers, and oligonucleotides for various diagnostic tests. These diagnostic methods aid in the identification of specific genetic variants, mutations, or infections that cause diseases.
The market is divided into two categories based on End-User: Biotechnology companies, Academic and Research Organizations, and Contract Research Organizations (CROs). Biotechnology companies dominate the market and are likely to maintain their dominance during the forecast period. Biotechnology companies are conducting a lot of research on gene synthesis and gene editing. DNA synthesizers enable researchers to make custom DNA sequences, which is necessary to make gene variants, gene knockouts, and modified genetic structures.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the DNA Synthesizers Market, due to Rising demand for diagnostic activities for multiple diseases. DNA synthesizers are used to create the primers needed for PCR, which allows for the selective amplification of specific DNA sequences, which aids in the diagnosis of various illnesses. The Leukemia & Lymphoma Society's mission predicted that Blood cancer molecular diagnostics is usually performed based on platforms such as PCR. An estimated combined total of 186,400 people in the US are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2021. New cases of leukemia, lymphoma, and myeloma are expected to account for 9.8 percent of the estimated 1,898,160 new cancer cases that will be diagnosed in the US in 2021. Europe is expected to drive the growth of DNA Synthesizers Market in the forecast period, due to the increasing prevalence of diseases and the need for precise and rapid diagnostics.
The demand for DNA synthesizers has been steadily increasing due to the growing focus on understanding the genetic basis of diseases, cellular processes, and biological pathways. To maintain their market positions, these organizations compete on aspects such as product performance, reliability, ease of use, automation possibilities, and customer service. The DNA Synthesizers market is characterized by several prominent players that offer a range of instruments and solutions to meet the diverse needs of researchers and industries. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For example, on 5 August 2020, Paris-based DNA synthesis company DNA Script announced a USD50 million extension to its Series B financing, bringing the total investment of this round to USD89 million.
November 23, 2021, Codex DNA is buying Eton Bioscience, a privately held provider of synthetic biology products and services, for USD13 million. Codex DNA officials said the acquisition will allow the company to expand its commercial BioXp system and foundry service offerings as well as reduce raw material costs and accelerate overall growth.